DALDURI Trademark

Trademark Overview

On Tuesday, April 5, 2005, a trademark application was filed for DALDURI with the United States Patent and Trademark Office. The USPTO has given the DALDURI trademark a serial number of 79013551. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, December 8, 2021. This trademark is owned by Novartis AG. The DALDURI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, immune system, cardiovascular system, respiratory system, musculoskeletal system, genito-urinary system, for the treatment of inflammatory disorders, for use in the fields of gastroenterology, dermatology, haematology, oncology, ophthalmology, in transplantation, and for the prevention and treatment of ocular disorders or diseases; anti-infectives, pharmaceutical preparations for the treatment of bacterial-based diseases, antivirals, antibiotics and antifungals
dalduri

General Information

Serial Number79013551
Word MarkDALDURI
Filing DateTuesday, April 5, 2005
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, December 8, 2021
Registration Number3130107
Registration DateTuesday, August 15, 2006
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 23, 2006

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the nervous system, immune system, cardiovascular system, respiratory system, musculoskeletal system, genito-urinary system, for the treatment of inflammatory disorders, for use in the fields of gastroenterology, dermatology, haematology, oncology, ophthalmology, in transplantation, and for the prevention and treatment of ocular disorders or diseases; anti-infectives, pharmaceutical preparations for the treatment of bacterial-based diseases, antivirals, antibiotics and antifungals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 20, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Sunday, September 25, 2022NOTIFICATION PROCESSED BY IB
Monday, May 9, 2022NOTIFICATION PROCESSED BY IB
Thursday, December 30, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Thursday, December 30, 2021DEATH OF INTERNATIONAL REGISTRATION
Friday, September 9, 2016NOTIFICATION PROCESSED BY IB
Friday, October 23, 2015NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, October 23, 2015DEATH OF INTERNATIONAL REGISTRATION
Friday, December 19, 2014TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, October 2, 2014GENERIC MADRID TRANSACTION SENT TO IB
Thursday, October 2, 2014GENERIC MADRID TRANSACTION CREATED
Tuesday, May 20, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 20, 2013CANCELLED SECTION 71
Friday, April 12, 2013NEW REPRESENTATIVE AT IB RECEIVED
Saturday, February 23, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, June 18, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 18, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, April 13, 2007FINAL DISPOSITION NOTICE SENT TO IB
Friday, April 13, 2007FINAL DISPOSITION PROCESSED
Tuesday, April 10, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 15, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, May 23, 2006PUBLISHED FOR OPPOSITION
Wednesday, May 3, 2006NOTICE OF PUBLICATION
Tuesday, March 28, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, February 24, 2006ASSIGNED TO LIE
Thursday, February 23, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, February 18, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 9, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 9, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 6, 2006ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 6, 2006TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 9, 2005REFUSAL PROCESSED BY IB
Thursday, November 17, 2005NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, November 13, 2005NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, November 12, 2005NON-FINAL ACTION WRITTEN
Wednesday, November 9, 2005NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Monday, November 7, 2005NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, November 1, 2005ASSIGNED TO EXAMINER
Monday, September 12, 2005NEW APPLICATION ENTERED IN TRAM
Thursday, September 8, 2005SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

dalduri system treatment disorders pharmaceutical preparations diseases prevention ocular ophthalmology anti